Proteome Sciences (LON:PRM) Trading 4.7% Higher – Time to Buy?

Proteome Sciences plc (LON:PRM)’s share price rose 4.7% during trading on Friday . The company traded as high as GBX 4.98 ($0.06) and last traded at GBX 4.70 ($0.06). Approximately 192,580 shares were traded during mid-day trading, an increase of 10% from the average daily volume of 175,323 shares. The stock had previously closed at GBX 4.49 ($0.06).

Proteome Sciences Stock Up 8.5 %

The business’s fifty day moving average price is GBX 3.89 and its 200 day moving average price is GBX 3.27. The firm has a market capitalization of £14.37 million, a price-to-earnings ratio of -3.52 and a beta of 0.07. The company has a current ratio of 0.20, a quick ratio of 0.37 and a debt-to-equity ratio of -258.66.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.